Search research articles
Contact Us
Filters
Showing results (221-230 of 263) with videos related to
Page
of 27
Sort By:
HIV Medicine
|
January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection
J J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine
|
January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study
E Ribera, M Larrousse, A Curran, et al.
Molecular Pharmacology
|
January 12, 1999
Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor
J A Esté, C Cabrera, E De Clercq, et al.
HIV Medicine
|
December 16, 2014
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio
E Martínez, E Ribera, B Clotet, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
December 8, 2000
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]
J M Miró, A Antela, J Arrizabalaga, et al.
AIDS Care
|
November 30, 2006
Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients
C R Fumaz, J A Muñoz-Moreno, A L Ballesteros, et al.
AIDS (London, England)
|
April 1, 1997
Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy
V Soriano, U Dietrich, N Villalba, et al.
AIDS (London, England)
|
December 1, 1996
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC
L Ruiz, J Romeu, J Martínez-Picado, et al.
The Journal of Infectious Diseases
|
June 3, 1999
Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load
A Arnó, L Ruiz, M Juan, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
January 12, 2001
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)]
J M Miró, A Antela, J Arrizabalaga, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 263) with videos related to
Sort By:
Page
of 27
HIV Medicine
|
January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection
J J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine
|
January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study
E Ribera, M Larrousse, A Curran, et al.
Molecular Pharmacology
|
January 12, 1999
Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor
J A Esté, C Cabrera, E De Clercq, et al.
HIV Medicine
|
December 16, 2014
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio
E Martínez, E Ribera, B Clotet, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
December 8, 2000
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]
J M Miró, A Antela, J Arrizabalaga, et al.
AIDS Care
|
November 30, 2006
Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients
C R Fumaz, J A Muñoz-Moreno, A L Ballesteros, et al.
AIDS (London, England)
|
April 1, 1997
Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy
V Soriano, U Dietrich, N Villalba, et al.
AIDS (London, England)
|
December 1, 1996
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC
L Ruiz, J Romeu, J Martínez-Picado, et al.
The Journal of Infectious Diseases
|
June 3, 1999
Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load
A Arnó, L Ruiz, M Juan, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
January 12, 2001
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)]
J M Miró, A Antela, J Arrizabalaga, et al.
Page
of 27